1. 2022
  2. Quantified integrated hepatitis B virus is related to viral activity in patients with chronic hepatitis B

    Erken, R., Loukachov, V., van Dort, K., van den Hurk, A., Takkenberg, R. B., de Niet, A., Jansen, L., Willemse, S., Reesink, H. & Kootstra, N., Jul 2022, In: Hepatology. 76, 1, p. 196-206 11 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. Reply

    Loukachov, V. V., van Dort, K. A., Erken, R., Reesink, H. W. & Kootstra, N. A., Jul 2022, In: Hepatology. 76, 1, p. E24

    Research output: Contribution to journalComment/Letter to the editorAcademic

  4. The history of buffy coat platelet concentrates: The Dutch story

    van der Meer, P. F., Reesink, H. W., de Korte, D., Loos, J. A. & Klei, T. R. L., Jul 2022, In: Vox sanguinis. 117, 7, p. 913-919 7 p.

    Research output: Contribution to journalReview articleAcademicpeer-review

  5. Identification of Liver and Plasma microRNAs in Chronic Hepatitis B Virus infection

    Loukachov, V. V., van Dort, K. A., Maurer, I., Takkenberg, R. B., de Niet, A., Reesink, H. W., Willemse, S. B. & Kootstra, N. A., 2 Jun 2022, In: Frontiers in cellular and infection microbiology. 12, 790964.

    Research output: Contribution to journalArticleAcademicpeer-review

  6. Identification of a Novel HBV Encoded miRNA Using Next Generation Sequencing

    Loukachov, V., van Dort, K. A., Jansen, L., Reesink, H. W. & Kootstra, N. A., 1 Jun 2022, In: Viruses. 14, 6, 1223.

    Research output: Contribution to journalArticleAcademicpeer-review

  7. A Prospective Five-Year Follow-up After peg-Interferon Plus Nucleotide Analogue Treatment or no Treatment in HBeAg Negative Chronic Hepatitis B Patients

    Erken, R., Loukachov, V. V., de Niet, A., Jansen, L., Stelma, F., Helder, J. T., Peters, M. W., Zaaijer, H. L., Kootstra, N. A., Willemse, S. B. & Reesink, H. W., 1 May 2022, In: Journal of Clinical and Experimental Hepatology. 12, 3, p. 735-744 10 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  8. Reply

    Loukachov, V., van Dort, K., Erken, R., Reesink, H. W. & Kootstra, N., 2022, (E-pub ahead of print) In: Hepatology.

    Research output: Contribution to journalComment/Letter to the editorAcademic

  9. 2021
  10. Farnesoid X receptor agonist for the treatment of chronic hepatitis B: A safety study

    Erken, R., Andre, P., Roy, E., Kootstra, N., Barzic, N., Girma, H., Laveille, C., Radreau-Pierini, P., Darteil, R., Vonderscher, J., Scalfaro, P., Tangkijvanich, P., Flisiak, R. & Reesink, H., Dec 2021, In: Journal of viral hepatitis. 28, 12, p. 1690-1698 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  11. 2019
  12. Long-term follow-up of patients treated with entecavir and peginterferon add-on therapy for HBeAg-positive chronic hepatitis B infection: ARES long-term follow-up

    ARES Study Group, van Campenhout, M. J. H., Brouwer, W. P., Xie, Q., Guo, S., Chi, H., Qi, X., Tabak, F., Streinu-Cercel, A., Wang, J-Y., Zhang, N-P., Idilman, R., Reesink, H. W., Diculescu, M., Simon, K., Akdogan, M., Mazur, W. O., de Knegt, R. J., Verhey, E., Hansen, B. E., & 1 othersJanssen, H. L. A., 1 Jan 2019, In: Journal of viral hepatitis. 26, 1, p. 109-117 9 p.

    Research output: Contribution to journalArticleAcademicpeer-review

Previous 1 2 3 4 5 6 7 8 ...36 Next

ID: 80187